Chemoinformaics analysis of 5,6,7-TRIMETHOXY-2-METHYLISOQUINOLIN-1-ONE
| Molecular Weight | 249.266 | nRot | 3 |
| Heavy Atom Molecular Weight | 234.146 | nRig | 6 |
| Exact Molecular Weight | 249.1 | nRing | 2 |
| Solubility: LogS | -1.973 | nHRing | 1 |
| Solubility: LogP | 2.848 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 15 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 11 |
| nHA | 5 | APOL | 36.0199 |
| nHD | 0 | BPOL | 22.8341 |
| QED | 0.662 |
| Synth | 2.292 |
| Natural Product Likeliness | -0.45 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.012 |
| Pgp-sub | 0.002 |
| HIA | 0.006 |
| CACO-2 | -4.562 |
| MDCK | 0.0000236 |
| BBB | 0.986 |
| PPB | 0.606998 |
| VDSS | 1.222 |
| FU | 0.32209 |
| CYP1A2-inh | 0.671 |
| CYP1A2-sub | 0.944 |
| CYP2c19-inh | 0.06 |
| CYP2c19-sub | 0.833 |
| CYP2c9-inh | 0.027 |
| CYP2c9-sub | 0.273 |
| CYP2d6-inh | 0.174 |
| CYP2d6-sub | 0.775 |
| CYP3a4-inh | 0.055 |
| CYP3a4-sub | 0.302 |
| CL | 5.848 |
| T12 | 0.396 |
| hERG | 0.03 |
| Ames | 0.009 |
| ROA | 0.595 |
| SkinSen | 0.729 |
| Carcinogencity | 0.275 |
| EI | 0.947 |
| Respiratory | 0.946 |
| NR-Aromatase | 0.03 |
| Antiviral | Yes |
| Prediction | 0.729489 |